首页|结节性硬化症患儿52例临床表型及基因型特点分析

结节性硬化症患儿52例临床表型及基因型特点分析

扫码查看
目的 分析52例结节性硬化症患儿的临床表型及TSC1/TSC2基因变异情况.方法 收集2017年1月至2022年10月就诊于临沂市人民医院的59例结节性硬化症患儿的临床资料,对其主要家系成员进行TSC1及TSC2基因检测,分析致病性,并将基因检测阳性患儿分为TSC1基因变异组和TSC2基因变异组,比较两组的临床特征差异性.结果 59例患儿中有52例检出TSC1或TSC2基因变异(包括TSC1基因变异17例,TSC2基因变异35例).52例患儿中男性28例(53.8%),女性24例(46.2%);家族性病例17例(32.7%,包括TSC1基因变异10例,TCS2基因变异7例),散发病例35例(67.3%);皮肤色素脱失斑46例(88.5%),面部血管纤维瘤13例(25.0%),鲨革斑5例(9.6%),室管膜下结节/钙化49例(94.2%),皮质结节47例(90.4.%),室管膜下巨细胞星型细胞瘤2例(3.8%),智力障碍/发育迟缓39例(75.0%),癫痫发作49例(94.2%),心脏横纹肌瘤8例(15.4%),肾血管平滑肌脂肪瘤9例(17.3%),视网膜错构瘤4例(7.7%).基因检测共检出49种变异,4种为大片段缺失/重复变异,45种为点变异.其中致病性变异41种,可能致病性变异7种,意义未明确1种.共发现国内外尚未见报道的变异位点16种、重复大片段1种.3个高频变异位点为p.Arg692*、p.Arg228*和p.Arg1200Try.TSC1基因变异组和TSC2基因变异组患儿在阳性家族史占比[10/17比7/35(20%),x2=7.838,P=0.005]、癫痫起病月龄[38.0(0.5~134.0)个月比8.0(0.1~63.0)个月,Z=3.506,P<0.001]及智力障碍/发育迟缓发生率[8/17比31/35(88.6%),x2dj=8.423,P=0.004]上差异具有统计学意义.结论 TSC临床表型谱广泛,可累及全身各个系统,主要为皮肤及神经系统.致病基因为TSC1/TSC2.TSC1基因变异患儿多有家族遗传,TSC2基因变异患儿癫痫起病年龄更早且智力障碍/发育迟缓发生率更高.本研究发现了未见报道的变异位点16种、重复大片段1种,热点变异3种,扩展了结节性硬化症的基因谱.
Clinical phenotype and genotype characteristics of tuberous sclerosis complex in 52 children
Objective To analyze the clinical phenotypes and TSC1/TSC2 gene variations in 52 children with tuberous sclerosis complex.Methods The clinical data of 59 children with tuberous sclerosis complex hospitalized in Linyi People's Hospital between January 2017 and October 2022 were collected.The analysis of TSC1 and TSC2 gene variations on main family members was performed,and then bioinformatics analysis followed.The positive children were divided into TSC1 gene group and TSC2 gene group,and the difference of clinical characteristics between the two groups was analyzed.Results Among 59 children,52 cases were detected TSC1/TSC2 gene variations(17 cases in the TSC1 gene group and 35 cases in the TSC2 gene group).Of the 52 children,28(53.8%)were male,24 were female(46.2%);17(32.7%)were familial cases(10 with TSC1 gene variations and 7 with TSC2 gene variations),35(67.3%)were sporadic cases;46(88.5%)had hypomelanotic macules,13(25.0%)had facial angiofibromas,5(9.6%)had shagreen patches,49(94.2%)had subependymal nodules/calcifications,47(90.4%)had cortical nodules,2(3.8%)had subependymal giant cell astrocytomas,39(75.0%)had intellectual/developmental disabilities,49(94.2%)had epileptic seizures,8(15.4%)had cardiac rhabdomyomas,9(17.3%)had renal angiomyolipomas,and 4(7.7%)had retinal hamartomas.Of the 52 children,49 variations were detected,including 4 large fragment deletion/duplication variations,and 45 point variations;41 pathogenic variations,7 likely pathogenic variations,and 1 variation of uncertain significance.In this study,16 point mutations and 1 large fragment duplication mutation which had not been reported at home and abroad,and 3 high-frequency mutation sites(p.Arg692*,p.Arg228*,and p.Arg1200Try)were found.There was a statistically significant difference in the proportion of familial cases[10/17 vs 7/35(20%),x2=7.838,P=0.005],median onset age of epilepsy[38.0(0.5-134.0)months vs 8.0(0.1-63.0)months,Z=3.506,P<0.001]and the incidence of developmental retardation/intellectual impairment[8/17 vs 31/35(88.6%),x2adj=8.423,P=0.004]between the TSC1 gene and TSC2 gene groups.Conclusions Tuberous sclerosis compiex has widespread phenotypes,can affect every body system,especially the skin and nervous system.The pathogenic gene is TSC1/TSC2.The TSC1 gene group has more familial cases.The TSC2 gene group has an earlier onset age of epilepsy and a higher incidence of developmental retardation/intellectual impairment.In this study,16 novel point mutations,1 novel large fragment duplication mutation,and 3 hotspot mutations were identified,expanding the gene variation spectrum of tuberous sclerosis complex.

Tuberous sclerosisChildMutationGenotypeTSC1/TSC2 gene

徐那、杨莉、邱世彦、张新、李玉芬、韩玉增、徐丽云、朱丽萍

展开 >

临沂市人民医院儿科,临沂 276000

结节性硬化症 儿童 突变 基因型 TSC1/TSC2基因

临沂市重点研发计划

2023YX0005

2024

中华神经科杂志
中华医学会

中华神经科杂志

CSTPCD北大核心
影响因子:1.329
ISSN:1006-7876
年,卷(期):2024.57(4)
  • 23